Chadwick David R
Consultant Endocrine Surgeon, Nottingham University Hospitals, City Campus, Nottingham, UK.
Gland Surg. 2017 Dec;6(Suppl 1):S69-S74. doi: 10.21037/gs.2017.09.14.
The UK Registry of Endocrine and Thyroid Surgeons (UKRETS) has been operated by the British Association of Endocrine and Thyroid Surgeons (BAETS) and Dendrite Clinical Systems Ltd. in a web-based electronic format since 2004. Data on over 90,000 endocrine procedures have been collected to date. Analysis of those cases undergoing bilateral thyroid resections in the interval July 2010 to June 2015 demonstrates that hypocalcaemia remains the commonest complication of thyroid surgery. After first-time total thyroidectomy, 23.6% of patients develop hypocalcaemia, defined as a serum calcium <2.10 mmol/L (or <1.20 mmol/L ionized calcium) on the first post-operative day. Most require treatment with calcium +/- vitamin D supplements, with around 38% of all patients being treated by the time of discharge from the index admission. By 6 months post-operative, 7.3% of patients remain on calcium/vitamin D supplements, reflecting persistent (though not necessarily permanent) hypoparathyroidism. Risk factors for persistent hypocalcaemia are principally concomitant level VI lymph node dissection [odds ratio (OR) =2.73]; re-operative surgery (OR =1.44); and inter-surgeon variation.
自2004年以来,英国内分泌与甲状腺外科医生注册机构(UKRETS)一直由英国内分泌与甲状腺外科医生协会(BAETS)和Dendrite临床系统有限公司以基于网络的电子形式运营。迄今为止,已收集了超过90,000例内分泌手术的数据。对2010年7月至2015年6月期间接受双侧甲状腺切除术的病例分析表明,低钙血症仍然是甲状腺手术最常见的并发症。首次全甲状腺切除术后,23.6%的患者出现低钙血症,定义为术后第一天血清钙<2.10 mmol/L(或离子钙<1.20 mmol/L)。大多数患者需要补充钙和/或维生素D进行治疗,约38%的患者在本次住院出院时接受了治疗。术后6个月时,7.3%的患者仍在补充钙/维生素D,这反映了持续性(但不一定是永久性)甲状旁腺功能减退。持续性低钙血症的危险因素主要是同时进行Ⅵ区淋巴结清扫[比值比(OR)=2.73];再次手术(OR =1.44);以及外科医生之间的差异。